Repare Therapeutics (RPTX) said Monday it appointed Steve Forte as president, chief executive, and member of the company's board, starting from April 11.
Forte is currently the chief financial officer at the company. He will replace Lloyd Segal, who resigned to pursue other opportunities.
Forte will also remain the company's CFO, Repare said.
Meanwhile, Sandra Alves, the company's corporate controller, was promoted to chief accounting officer, Repare said.
Repare shares were up more than 4% in after-hours activity.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.